1-1 of 1
Melanie Farnsworth
Close
Sort by
Journal Articles

Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate

Clinical Trials & Observations
Michael E. O'Dwyer, Michael J. Mauro, Carolyn Blasdel, Melanie Farnsworth, Gwen Kurilik, Yi-Ching Hsieh, Motomi Mori, Brian J. Druker
Journal: Blood
Blood (2004) 103 (2): 451–455.
https://doi.org/10.1182/blood-2003-02-0371
Published: 2004